DP

English translation: Drug Product

GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW)
Italian term or phrase:DP
English translation:Drug Product
Entered by: Luigi Argentino

14:43 Oct 31, 2019
Italian to English translations [PRO]
Medical - Medical: Pharmaceuticals / qualified person's (QP) declaration concerning good manufacturing practice compliance of active substance manufacture
Italian term or phrase: DP
ds is drug substance i think, what might DP be?
App.9 (Vers. 1.3 datata 08.10.2019)
Per la sperimentazione clinica in oggetto è stata presentata una richiesta di Emendamento Sostanziale “Brexit QP declaration per il nuovo sito”. Dopo una prima valutazione erano emerse delle richieste alle quali il Promotore ha risposto inviando le seguenti QP declaration:
- Em004 QP declaration for PF-06804103 2017-002538-22 C0541001 dated 14-Aug-2019 (GC).docx_1
- Em004 QP declaration for PF-06804103 2017-002538-22 C0541001 dated 14-Aug-2019 (SW).docx
- Em004 QP Declaration for PF-06804103 2017-002538-22 C0541001 DS dated 14-Aug-2019 (GC).docx
- Em004 QP Declaration for PF-06804103 2017-002538-22 C0541001 DS dated 14-Aug-2019 (SW).docx
Come richiesto in fase di valutazione, il Promotore ha fornito nuove QP declaration sottoscritte dalle QP del sito UK Pfizer Limited Sandwich con il MIA (IMP) 57 e del nuovo sito irlandese Pfizer Grange Castle con il MIA IMP115100, indicato come responsabile del rilascio dei lotti dopo la Brexit.
Ai fini della richiesta di emendamento in oggetto la documentazione presentata è accettabile.
Tuttavia, si richiama l’attenzione dell’Autorità competente, poiché il Promotore ha presentato oltre alla documentazione in risposta alle richieste sollevate, la seguente documentazione aggiuntiva:
- S.2 MANUFACTURE – PF-06758921 (PT-183/290) per il prodotto intermedio
- S.2. MANUFACTURE per la DS
- P.3. MANUFACTURE per il DP.
garrett higgins
Local time: 11:29
Drug Product
Explanation:
A suggestion. I'm looking for the references

--------------------------------------------------
Note added at 11 mins (2019-10-31 14:55:21 GMT)
--------------------------------------------------

Here it is:
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&c...

--------------------------------------------------
Note added at 13 mins (2019-10-31 14:57:25 GMT)
--------------------------------------------------

"For some ATMPs, the starting material, the active substance and the finished product can be closely related or nearly identical. In some cases, an artificial (based on regulatory reasons) distinction between drug substance (DS) and drug product (DP) might be included in the IMPD, but this is not always possible. In general, these distinctions are done based on the individual characteristics of each product. When feasible, the applicant should clearly define in the IMPD what it is considered intermediate products, what is considered drug substance and drug product. Starting from these definitions and based on characterization studies, appropriate in-process and release controls need to be established for each step. It is acknowledged that, depending on the product and on the manufacturing process, and when appropriately justified, release testing of the final product might be performed at earlier stages in the manufacturing process."
Selected response from:

Luigi Argentino
Italy
Local time: 12:29
Grading comment
thanks
4 KudoZ points were awarded for this answer



Summary of answers provided
3 +1Drug Product
Luigi Argentino


Discussion entries: 6





  

Answers


9 mins   confidence: Answerer confidence 3/5Answerer confidence 3/5 peer agreement (net): +1
Drug Product


Explanation:
A suggestion. I'm looking for the references

--------------------------------------------------
Note added at 11 mins (2019-10-31 14:55:21 GMT)
--------------------------------------------------

Here it is:
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&c...

--------------------------------------------------
Note added at 13 mins (2019-10-31 14:57:25 GMT)
--------------------------------------------------

"For some ATMPs, the starting material, the active substance and the finished product can be closely related or nearly identical. In some cases, an artificial (based on regulatory reasons) distinction between drug substance (DS) and drug product (DP) might be included in the IMPD, but this is not always possible. In general, these distinctions are done based on the individual characteristics of each product. When feasible, the applicant should clearly define in the IMPD what it is considered intermediate products, what is considered drug substance and drug product. Starting from these definitions and based on characterization studies, appropriate in-process and release controls need to be established for each step. It is acknowledged that, depending on the product and on the manufacturing process, and when appropriately justified, release testing of the final product might be performed at earlier stages in the manufacturing process."


Luigi Argentino
Italy
Local time: 12:29
Specializes in field
Native speaker of: Italian
PRO pts in category: 68
Grading comment
thanks
Notes to answerer
Asker: brilliant


Peer comments on this answer (and responses from the answerer)
agree  philgoddard: Well done!
56 mins
  -> Thanks
Login to enter a peer comment (or grade)



Login or register (free and only takes a few minutes) to participate in this question.

You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.

KudoZ™ translation help

The KudoZ network provides a framework for translators and others to assist each other with translations or explanations of terms and short phrases.


See also:
Term search
  • All of ProZ.com
  • Term search
  • Jobs
  • Forums
  • Multiple search